FDA 510(k)

SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)

N.º K: K252463 · 2026-07-02

Fecha de decisión2026-07-02

Código de productoDPS

Comité asesorCV

DecisiónSubstantially Equivalent

Resumen del dispositivo

SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E) is the device name listed in this FDA 510(k) record. The listed applicant is Edan Instruments, Inc.. It received FDA 510(k) clearance on 2026-07-02 under 510(k) number K252463. The device is classified under product code DPS. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)?

SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E) is a medical device that received FDA 510(k) clearance on 2026-07-02. The listed applicant is Edan Instruments, Inc.. The 510(k) number is K252463.

When did SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E) receive FDA 510(k) clearance?

SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E) received FDA 510(k) clearance on 2026-07-02, under 510(k) number K252463.

Who is the listed applicant for SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)?

The FDA 510(k) record lists Edan Instruments, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)?

The FDA product code for SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E) is DPS.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Edan Instruments, Inc. como solicitante

K251508Telemetry Monitor (iT30, iT50)K251591Holter ECG and ABP system (HolterABP)K251268Diagnostic Ultrasound System (Nano C5, Nano C5 EXP, Nano L12, and Nano L12 EXP)K241882Fetal & Maternal Monitor (F15A, F15A Air)K250179Patient Monitor (CX10, CX12, CX15, UX10, UX12, UX15)K250214Acclarix AX8 Serie Diagnóstico de Ultrasonido Sistema (Modelo: Acclarix AX7, Acclarix AX8, Acclarix AX75, Acclarix AX78, Acclarix AX8 Exp, Acclarix AX8 Super), Acclarix AX9 Serie Diagnóstico de Ultrasonido Sistema (Modelo: Acclarix AX9 Básico, Acclarix AX9, Acclarix AX9 Exp, Acclarix AX9 Super, Acclarix AX85, Acclarix AX88)

Ver todos los 50 dispositivos →

Dispositivos relacionados (Código: DPS)

K254255S-Patch CardioAIWellysis Corp.K251670MAC 7 Resting ECG Analysis SystemGe Medical Systems Information Technologies, Inc.K252361AccurECG Analysis System (v2.0)Accurkardia, Inc.K252474Withings BeamO (SCT02)Withings K250569Cardiologs Holter PlatformPhilips France Commercial K243252ZBPro DiagnosticZbeats, Inc.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.